Literature DB >> 10792510

Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice.

T Sakai1, H Hisaeda, Y Nakano, H Ishikawa, Y Maekawa, K Ishii, Y Nitta, J Miyazaki, K Himeno.   

Abstract

An interleukin-12 (IL-12) expression plasmid was transferred, using a gene gun, to mice infected with Leishmania major or Trypanosoma cruzi. Transfer of the IL-12 gene to susceptible BALB/c mice resulted in regression of lesion size and reduced the number of parasites in draining lymph nodes (LN) at the site of L. major infection. Coincident with these protective effects, the T-helper type (Th) response shifted towards Th1, as evaluated by cytokine production in vitro and L. major-specific antibody responses. Protective effects of the IL-12 gene were also observed in T. cruzi infection. Treatment of BALB/c mice infected with T. cruzi enhanced the production of interferon-gamma (IFN-gamma) by spleen cells, while suppressed production of interleukin-10 (IL-10) compared with control mice. Administration of anti-CD4 or anti-CD8 monoclonal antibody (mAb) abolished the protective immunity against T. cruzi infection, and treatment with the IL-12 gene could not restore the resistance in these mice. Mice depleted of natural killer (NK) cells with anti-asialo GM1 also became susceptible to infection, while the resistance was restored when these mice were treated with the IL-12 gene. Thus, target cells for the treatment appear to be CD4+ and CD8+ T cells, which are ordinarily activated by NK cells. These results suggest that the transfer of cytokine genes using a gene gun is an effective method for investigating the roles of cytokines and gene therapy in infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792510      PMCID: PMC2327200          DOI: 10.1046/j.1365-2567.2000.00989.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

Review 1.  Interleukin-12: a cytokine at the interface of inflammation and immunity.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1998       Impact factor: 3.543

2.  DNA-based immunization by in vivo transfection of dendritic cells.

Authors:  C Condon; S C Watkins; C M Celluzzi; K Thompson; L D Falo
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

3.  Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10.

Authors:  E Manickan; M Daheshia; N Kuklin; S Chun; B T Rouse
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 4.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

Review 5.  Gene vaccination: plasmid DNA is more than just a blueprint.

Authors:  H Tighe; M Corr; M Roman; E Raz
Journal:  Immunol Today       Date:  1998-02

Review 6.  DNA vaccines.

Authors:  J J Donnelly; J B Ulmer; J W Shiver; M A Liu
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

7.  Cytokine gene therapy of cancer using gene gun technology: superior antitumor activity of interleukin-12.

Authors:  A L Rakhmilevich; K Janssen; J Turner; J Culp; N S Yang
Journal:  Hum Gene Ther       Date:  1997-07-20       Impact factor: 5.695

8.  Interleukin-12 is indispensable for protective immunity against Leishmania major.

Authors:  F Mattner; K Di Padova; G Alber
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

9.  Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice.

Authors:  Y Nitta; F Tashiro; M Tokui; A Shimada; I Takei; K Tabayashi; J Miyazaki
Journal:  Hum Gene Ther       Date:  1998-08-10       Impact factor: 5.695

10.  Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

Authors:  A Porgador; K R Irvine; A Iwasaki; B H Barber; N P Restifo; R N Germain
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  12 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 2.  Concepts of immunostimulation to increase antiparasitic drug action.

Authors:  K Noel Masihi
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

3.  Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.

Authors:  Y Nakano; H Hisaeda; T Sakai; M Zhang; Y Maekawa; T Zhang; M Nishitani; H Ishikawa; K Himeno
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

4.  Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.

Authors:  Nisha Garg; Rick L Tarleton
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Ubiquitin-fusion degradation pathway plays an indispensable role in naked DNA vaccination with a chimeric gene encoding a syngeneic cytotoxic T lymphocyte epitope of melanocyte and green fluorescent protein.

Authors:  Manxin Zhang; Kazunari Ishii; Hajime Hisaeda; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Yang Li; Chikage Obata; Masutaka Furue; Kunisuke Himeno
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

6.  Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.

Authors:  Luiz Roberto Sardinha; Rosa Maria Elias; Tainá Mosca; Karina R B Bastos; Cláudio R F Marinho; Maria Regina D'Império Lima; José M Alvarez
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.

Authors:  Masaharu Katae; Yasushi Miyahira; Kazuyoshi Takeda; Hironori Matsuda; Hideo Yagita; Ko Okumura; Tsutomu Takeuchi; Tsuneo Kamiyama; Akihiko Ohwada; Yoshinosuke Fukuchi; Takashi Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.

Authors:  José E Aparicio-Burgos; Laucel Ochoa-García; José Antonio Zepeda-Escobar; Shivali Gupta; Monisha Dhiman; José Simón Martínez; Roberto Montes de Oca-Jiménez; Margarita Val Arreola; Alberto Barbabosa-Pliego; Juan C Vázquez-Chagoyán; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2011-05-17

9.  Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C.

Authors:  H Rezvan; R Rees; Sa Ali
Journal:  Iran J Parasitol       Date:  2011-12       Impact factor: 1.012

Review 10.  Natural killer cells in experimental and human leishmaniasis.

Authors:  Christian Bogdan
Journal:  Front Cell Infect Microbiol       Date:  2012-05-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.